Nuclear receptors: Difference between revisions
No edit summary |
No edit summary |
||
Line 96: | Line 96: | ||
Similar differences may be observed between ER which has bound the partial agonist and complete antagonist ligands. <scene name='71/714947/Antagonist_tamoxifen_bound_er/5'>Antagonist tamoxifen bound ER</scene> The most drastic difference is noticeable between agonist and antagonist ligands. Compare the agonist scene to the <scene name='71/714947/Agonist_estradiol_bound_er/2'>Agonist estradiol bound er</scene>. Special attention should be given to the bottom right alpha helices and beta sheets that are pushed out more in the antagonist compared to the agonist bound ER. | Similar differences may be observed between ER which has bound the partial agonist and complete antagonist ligands. <scene name='71/714947/Antagonist_tamoxifen_bound_er/5'>Antagonist tamoxifen bound ER</scene> The most drastic difference is noticeable between agonist and antagonist ligands. Compare the agonist scene to the <scene name='71/714947/Agonist_estradiol_bound_er/2'>Agonist estradiol bound er</scene>. Special attention should be given to the bottom right alpha helices and beta sheets that are pushed out more in the antagonist compared to the agonist bound ER. | ||
===Estrogen receptor α=== | ===Estrogen receptor α=== | ||
* [[Estrogen receptor#Estrogen receptor α complexed with raloxifene and a corepressor peptide]] | * [[Estrogen receptor#Estrogen receptor α complexed with raloxifene and a corepressor peptide]] | ||
===Estrogen receptor β=== | ===Estrogen receptor β=== | ||
* [[Student Project 10 for UMass Chemistry 423 Spring 2015]] | * [[Student Project 10 for UMass Chemistry 423 Spring 2015]] |